AAA
PRAX icon

Affinity Asset Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Affinity Asset Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.9M Buy
185,000
+15,000
+9% +$4.75M 2.8% 7
2026
Q1 		$54.8M Sell
170,000
-15,000
-8% -$4.64M 2.83% 9
2025
Q4 		$54.5M Buy
+185,000
New +$34.5M 3.11% 8

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Affinity Asset Advisors's PRAX Position: Q2 2026 in Review

Affinity Asset Advisors increased its Praxis Precision Medicines (PRAX) stake by 8.8% in Q2 2026, buying an estimated $4.75M and bringing the position to 185,000 shares worth $61.9M. The position accounts for 2.8% of the portfolio, ranked #7.

Affinity Asset Advisors first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Affinity Asset Advisors held 185,000 shares of Praxis Precision Medicines worth $61.9M as of Q2 2026.
  • Affinity Asset Advisors bought 15,000 Praxis Precision Medicines shares in Q2 2026, an estimated $4.75M.
  • Praxis Precision Medicines made up 2.8% of Affinity Asset Advisors's portfolio in Q2 2026, its #7 holding.
  • Affinity Asset Advisors first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.